Suppr超能文献

重新将 translocator protein 概念化为精神病学中神经炎症的生物标志物。

Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry.

机构信息

Institute of Pharmacology and Toxicology, University of Zurich-Vetsuisse, Zurich, Switzerland.

Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland.

出版信息

Mol Psychiatry. 2018 Jan;23(1):36-47. doi: 10.1038/mp.2017.232. Epub 2017 Dec 5.

Abstract

A great deal of interest in psychiatric research is currently centered upon the pathogenic role of inflammatory processes. Positron emission tomography (PET) using radiolabeled ligands selective for the 18 kDa translocator protein (TSPO) has become the most widely used technique to assess putative neuroimmune abnormalities in vivo. Originally used to detect discrete neurotoxic damages, TSPO has generally turned into a biomarker of 'neuroinflammation' or 'microglial activation'. Psychiatric research has mostly accepted these denotations of TSPO, even if they may be inadequate and misleading under many pathological conditions. A reliable and neurobiologically meaningful diagnosis of 'neuroinflammation' or 'microglial activation' is unlikely to be achieved by the sole use of TSPO PET imaging. It is also very likely that the pathological meanings of altered TSPO binding or expression are disease-specific, and therefore, not easily generalizable across different neuropathologies or inflammatory conditions. This difficulty is intricately linked to the varying (and still ill-defined) physiological functions and cellular expression patterns of TSPO in health and disease. While altered TSPO binding or expression may indeed mirror ongoing neuroinflammatory processes in some cases, it may reflect other pathophysiological processes such as abnormalities in cell metabolism, energy production and oxidative stress in others. Hence, the increasing popularity of TSPO PET imaging has paradoxically introduced substantial uncertainty regarding the nature and meaning of neuroinflammatory processes and microglial activation in psychiatry, and likely in other neuropathological conditions as well. The ambiguity of conceiving TSPO simply as a biomarker of 'neuroinflammation' or 'microglial activation' calls for alternative interpretations and complimentary approaches. Without the latter, the ongoing scientific efforts and excitement surrounding the role of the neuroimmune system in psychiatry may not turn into therapeutic hope for affected individuals.

摘要

目前,精神科研究领域非常关注炎症过程的致病作用。使用放射性标记配体对 18 kDa 移位蛋白(TSPO)进行正电子发射断层扫描(PET)已成为评估体内潜在神经免疫异常的最广泛使用的技术。TSPO 最初用于检测离散的神经毒性损伤,现已普遍成为“神经炎症”或“小胶质细胞激活”的生物标志物。精神科研究大多接受了 TSPO 的这些定义,即使在许多病理条件下,这些定义可能不充分且具有误导性。仅使用 TSPO PET 成像不太可能可靠地且具有神经生物学意义地诊断“神经炎症”或“小胶质细胞激活”。改变的 TSPO 结合或表达的病理意义很可能是疾病特异性的,因此不易在不同的神经病理学或炎症条件下推广。这种困难与 TSPO 在健康和疾病中的生理功能和细胞表达模式的变化(且仍未明确定义)密切相关。虽然改变的 TSPO 结合或表达在某些情况下可能确实反映了正在进行的神经炎症过程,但在其他情况下,它可能反映了其他病理生理过程,例如细胞代谢、能量产生和氧化应激异常。因此,TSPO PET 成像的日益普及,给精神科以及其他神经病理学条件中神经炎症过程和小胶质细胞激活的性质和意义带来了巨大的不确定性,这具有矛盾性。将 TSPO 简单地视为“神经炎症”或“小胶质细胞激活”的生物标志物的这种模糊性,需要替代解释和补充方法。如果没有后者,围绕神经免疫系统在精神科中的作用的持续科学努力和兴奋可能不会为受影响的个体带来治疗希望。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验